Inhibition of toad urinary bladder sodium transport by carbamylcholine: possible role of cyclic GMP.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002024:Bufo marinus; D000001:Calcimycin / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology*; D006152:Cyclic GMP / Q000378:metabolism*; D066298:In Vitro Techniques; D012964:Sodium / Q000378:metabolism*; D001743:Urinary Bladder / Q000378:metabolism*; D014667:Vasopressins / Q000494:pharmacology
D014667:Vasopressins; D000001:Calcimycin; D000450:Aldosterone; D002217:Carbachol; D012964:Sodium; D006152:Cyclic GMP; D015056:1-Methyl-3-isobutylxanthine